BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24315314)

  • 1. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
    Spapen H; Spapen J; Taccone FS; Meersseman W; Rello J; Dimopoulos G; Charles PE; Rao R; Pérez M; Martin C; Vogelaers D; Blot SI;
    Int J Antimicrob Agents; 2014 Feb; 43(2):165-9. PubMed ID: 24315314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
    Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A
    Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
    Uçan ES; Avkan Oğuz V; Güngör O; Gülşen A; Uğural Sezak N; Tertemiz KC; Ceylan E; Kargi A; Balci P; Ada E; Sanli A
    Tuberk Toraks; 2006; 54(1):75-9. PubMed ID: 16615023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
    Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
    Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
    Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
    Hoenigl M; Krause R
    Curr Pharm Des; 2013; 19(20):3648-68. PubMed ID: 23278539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system].
    Ueno A; Hamano T; Fujii A; Matsunaga A; Naganuma S; Yoneda M; Itoh H; Kuriyama M
    Rinsho Shinkeigaku; 2009 Aug; 49(8):468-73. PubMed ID: 19827595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
    Russo A; Falcone M; Vena A; Venditti C; Mancini C; Morelli A; Venditti M
    J Chemother; 2011 Oct; 23(5):290-4. PubMed ID: 22005062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
    Dandachi D; Wilson Dib R; Fernández-Cruz A; Jiang Y; Chaftari AM; Hachem R; Raad I
    Ann Med; 2018 Dec; 50(8):713-720. PubMed ID: 30230385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.
    Machetti M; Zotti M; Veroni L; Mordini N; Van Lint MT; Bacigalupo A; Paola D; Viscoli C
    Transpl Infect Dis; 2000 Sep; 2(3):140-4. PubMed ID: 11429025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillus tracheobronchitis in critically ill patients with chronic obstructive pulmonary diseases.
    He H; Jiang S; Zhang L; Sun B; Li F; Zhan Q; Wang C
    Mycoses; 2014 Aug; 57(8):473-82. PubMed ID: 24673772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
    Ader F; Bienvenu AL; Rammaert B; Nseir S
    Int J Chron Obstruct Pulmon Dis; 2009; 4():279-87. PubMed ID: 19684861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system aspergillosis in immunocompetent patients: Case series and literature review.
    Ma Y; Li W; Ao R; Lan X; Li Y; Zhang J; Yu S
    Medicine (Baltimore); 2020 Oct; 99(44):e22911. PubMed ID: 33126348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
    J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Values of radiological examinations for the diagnosis and prognosis of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary diseases.
    Huang L; He H; Ding Y; Jin J; Zhan Q
    Clin Respir J; 2018 Feb; 12(2):499-509. PubMed ID: 27614086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
    Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
    Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pulmonary aspergillosis in solid-organ transplant patients in the intensive care unit.
    Klein J; Rello J; Dimopoulos G; Bulpa P; Blot K; Vogelaers D; Blot S
    Transpl Infect Dis; 2022 Feb; 24(1):e13746. PubMed ID: 34843161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.
    Vanderbeke L; Spriet I; Breynaert C; Rijnders BJA; Verweij PE; Wauters J
    Curr Opin Infect Dis; 2018 Dec; 31(6):471-480. PubMed ID: 30299367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.
    Delsuc C; Cottereau A; Frealle E; Bienvenu AL; Dessein R; Jarraud S; Dumitrescu O; Le Maréchal M; Wallet F; Friggeri A; Argaud L; Rimmelé T; Nseir S; Ader F
    Crit Care; 2015 Dec; 19():421. PubMed ID: 26631029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.